Brandon May

Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.

The effect of the COVID-29 pandemic on the hospital admissions and treatment adherences of patients with psoriasis are examined.

Researchers sought to investigate the association between sleep-disordered breathing and sleep-related hypoxia with SARS-CoV-2 infection and COVID-19 outcomes.

Does the prescription of antibiotics provide a meaningful clinical benefit for children who present with uncomplicated lower respiratory tract infections?

Researchers examined health disparities in the duration of asthma exacerbations in patients post-COVID-19.

People with diabetes are at a higher risk of experiencing poor outcomes after contracting COVID-19, including hospitalization and death. Researchers expanded on a previous analysis to identify risk factors for short-term adverse outcomes among veterans with diabetes and COVID-19.

The prevalence of COVID-19 in patients with chilblain-like lesions is assessed.

COVID-19 can cause additional complications and even death in people with a pre-existing conditions like type 2 diabetes. Researchers studied whether the medications people with type 2 diabetes often take were associated with a risk of dying from the virus.

Researchers evaluated the safety and efficacy of the investigational, microbiota-based, live biotherapeutic RBX2660 for treatment of recurrent C difficile infection.

Investigators assessed the frequency and severity of adverse events associated with H pylori treatments in clinical practice.